Vyome Holdings (HIND) Treasury Shares (2015 - 2025)

Vyome Holdings (HIND) posted quarterly Treasury Shares of $1.0 for Q2 2025, little changed quarter-over-quarter from $1.0 in Q1 2025.

Vyome Holdings (HIND) Treasury Shares (2015 - 2025) Analysis & Trends

Vyome Holdings' Treasury Shares history runs 11 years deep, the most recent figure standing at $1.0 for Q2 2025.

In Q2 2025, Treasury Shares changed N/A year-over-year to $1.0; the TTM figure through Jun 2025 stood at $1.0 (changed N/A YoY), while the FY2024 annual figure was $1.0, down 96.0% from the prior year.
Treasury Shares for Q2 2025 stood at $1.0, roughly flat from $1.0 in the prior quarter.
The five-year high for Treasury Shares was $1.8 million in Q3 2021, with the low at $1.0 in Q4 2024.
The 5-year median for Treasury Shares is $1761.0 (2023), against an average of $257101.9.
The sharpest annual moves came in 2021 and 2025: Treasury Shares jumped 1040.87% in 2021, then tumbled 99.9% in 2025.
Vyome Holdings' Treasury Shares stood at $34226.0 in 2021, then sank by 99.77% to $79.0 in 2022, then tumbled by 68.35% to $25.0 in 2023, then plunged by 96.0% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025.
Business Quant data shows HIND's Treasury Shares at $1.0 in Q2 2025, $1.0 in Q1 2025, and $1.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Vyome Holdings	16.07 Mn	8.18 Mn	11,658.00	-

Download Data